Farther Finance Advisors’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.56K Sell
1,880
-100
-5% -$444 ﹤0.01% 4861
2026
Q2
$10.8K Buy
1,980
+968
+96% +$3.71K ﹤0.01% 4372
2026
Q1
$2.25K Buy
1,012
+394
+64% +$1.25K ﹤0.01% 4861
2025
Q4
$2.47K Buy
618
+583
+1,666% +$3.24K ﹤0.01% 4607
2025
Q3
$296 Sell
35
-470
-93% -$4.56K ﹤0.01% 4643
2025
Q2
$5.69K Buy
505
+427
+547% +$3.92K ﹤0.01% 3312
2025
Q1
$755 Buy
78
+73
+1,460% +$737 ﹤0.01% 3693
2024
Q4
$56 Sell
5
-737
-99% -$13K ﹤0.01% 3862
2024
Q3
$21K Buy
742
+724
+4,022% +$18.7K ﹤0.01% 2055
2024
Q2
$331 Sell
18
-30
-63% -$766 ﹤0.01% 3373
2024
Q1
$1.53K Sell
48
-5
-9% -$160 ﹤0.01% 2602
2023
Q4
$1.75K Buy
+53
New +$1.5K ﹤0.01% 2487
2023
Q3
– Sell
-300
Closed -$9.09K – 2638
2023
Q2
$9.09K Hold
300
– – ﹤0.01% 1229
2023
Q1
$9.73K Hold
300
– – ﹤0.01% 1124
2022
Q4
$8.42K Buy
+300
New +$8.6K ﹤0.01% 998

Other funds holding EVH

Farther Finance Advisors's EVH Position: Q3 2026 in Review

Farther Finance Advisors reduced its Evolent Health (EVH) stake by 5.1% in Q3 2026, selling an estimated $444 and leaving 1,880 shares worth $6.56K. The position accounts for ﹤0.01% of the portfolio, ranked #4861.

Farther Finance Advisors first reported a position in EVH in Q4 2022 and has held it in 15 quarters since. The position peaked at $21K in Q3 2024. 6 funds tracked by Wall St. Rank hold EVH as of Q3 2026.

  • Farther Finance Advisors held 1,880 shares of Evolent Health worth $6.56K as of Q3 2026.
  • Farther Finance Advisors sold 100 Evolent Health shares in Q3 2026, an estimated $444.
  • Evolent Health made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4861 holding.
  • Farther Finance Advisors first reported a position in Evolent Health in Q4 2022 and has held it in 15 quarters since.
  • Farther Finance Advisors's Evolent Health position peaked at $21K in Q3 2024.
  • 6 funds tracked by Wall St. Rank held Evolent Health as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.